Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eden Blake-lea Maness, M.A.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Eden Maness's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Eden Maness has written about over time.
Humans, 1 publications between 2018 and 2018, average publication date August 2018. Neuropharmacology, 1 publications between 2018 and 2018, average publication date August 2018. Attention, 2 publications between 2018 and 2022, average publication date July 2020. Animals, 2 publications between 2018 and 2023, average publication date December 2020. Acetylcholine, 1 publications between 2022 and 2022, average publication date July 2022. Arousal, 1 publications between 2022 and 2022, average publication date July 2022. Locus Coeruleus, 1 publications between 2022 and 2022, average publication date July 2022. Norepinephrine, 1 publications between 2022 and 2022, average publication date July 2022. Parvalbumins, 1 publications between 2022 and 2022, average publication date July 2022. Wakefulness, 1 publications between 2022 and 2022, average publication date July 2022. Dizocilpine Maleate, 1 publications between 2023 and 2023, average publication date May 2023. Rats, 1 publications between 2023 and 2023, average publication date May 2023. Receptors, N-Methyl-D-Aspartate, 1 publications between 2023 and 2023, average publication date May 2023. Schizophrenia, 1 publications between 2023 and 2023, average publication date May 2023.

To see the data from this visualization as text, click here.
Maness's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.